These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23707163)

  • 21. Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand.
    Rochanathimoke O; Riewpaiboon A; Praditsitthikorn N; Tharmaphornpilas P; Jiamsiri S; Thavorncharoensap M; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):811-819. PubMed ID: 34008471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia.
    Lusvan ME; Debellut F; Clark A; Demberelsuren S; Otgonbayar D; Batjargal T; Purevsuren S; Groman D; Tate J; Pecenka C
    Vaccine; 2019 Feb; 37(6):798-807. PubMed ID: 30639458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
    Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
    PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of rotavirus vaccination in Turkey.
    Koksal T; Akelma AZ; Koksal AO; Kutukoglu I; Ozdemir O; Yuksel CN; Bozkaya D; Catal F; Sari S
    J Microbiol Immunol Infect; 2017 Oct; 50(5):693-699. PubMed ID: 27107612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of rotavirus vaccination in Albania.
    Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
    Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of routine infant rotavirus immunisation program in Japan.
    Hoshi SL; Kondo M; Okubo I
    Hum Vaccin Immunother; 2017 May; 13(5):1115-1125. PubMed ID: 27763810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
    Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
    Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
    J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of rotavirus vaccination in Armenia.
    Jit M; Yuzbashyan R; Sahakyan G; Avagyan T; Mosina L
    Vaccine; 2011 Nov; 29(48):9104-11. PubMed ID: 21945959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
    Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
    Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A cost-effectiveness analysis on universal infant rotavirus vaccination strategy in China].
    Sun SL; Gao YQ; Yin J; Zhuang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):238-42. PubMed ID: 26917523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
    Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
    Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
    Nonvignon J; Atherly D; Pecenka C; Aikins M; Gazley L; Groman D; Narh CT; Armah G
    Vaccine; 2018 Nov; 36(47):7215-7221. PubMed ID: 29223486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan.
    Sato T; Nakagomi T; Nakagomi O
    Jpn J Infect Dis; 2011; 64(4):277-83. PubMed ID: 21788701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana.
    Abbott C; Tiede B; Armah G; Mahmoud A
    Vaccine; 2012 Mar; 30(15):2582-7. PubMed ID: 22321664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
    Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
    Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
    Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N
    Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model.
    Alkoshi S; Orhun NM; Dahlui M
    Libyan J Med; 2014; 9(1):26236. PubMed ID: 25499622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of rotavirus vaccination programs in Taiwan.
    Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA
    Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.